Literature DB >> 17514019

Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework.

Robert Horne1, Vanessa Cooper, Grace Gellaitry, Heather Leake Date, Martin Fisher.   

Abstract

OBJECTIVE: To test the utility of the necessity-concerns framework in predicting highly active antiretroviral therapy (HAART) uptake and adherence.
METHODS: This was a prospective follow-up study. Consecutive patients who were not currently receiving HAART were referred by their HIV physician. Immediately after a recommendation of HAART, patients completed the Beliefs about Medicines Questionnaire assessing their perceptions of personal necessity for HAART and concerns about potential adverse effects. The influence of these beliefs on the decision to accept or decline HAART and adherence 12 months later were assessed.
RESULTS: One hundred fifty-three participants were given a recommendation of HAART, and 136 (88.9%) returned completed questionnaires. Thirty-eight participants (28%) initially rejected the treatment offer. Uptake of HAART was associated with perceptions of personal necessity for treatment (odds ratio [OR]=7.41, 95% confidence interval [CI]: 2.84 to 19.37) and concerns about potential adverse effects (OR=0.19, 95% CI: 0.07 to 0.48). There was a significant decline in adherence over time. Perceived necessity (OR=2.19, 95% CI: 1.02 to 4.71) and concerns about adverse effects (OR=0.45, 95% CI: 0.22 to 0.96), elicited before initiating HAART, predicted subsequent adherence. These associations were independent of clinical variables and depression.
CONCLUSIONS: The necessity-concerns framework is a useful theoretic model for understanding patient perspectives of HAART and predicting uptake and adherence, with implications for the design of evidence-based interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17514019     DOI: 10.1097/QAI.0b013e31806910e3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  69 in total

1.  Medication-related barriers to entering HIV care.

Authors:  Linda Beer; Jennifer L Fagan; Pamela Garland; Eduardo E Valverde; Barbara Bolden; Kathleen A Brady; Maria Courogen; Daniel Hillman; Alan Neaigus; Jeanne Bertolli
Journal:  AIDS Patient Care STDS       Date:  2012-02-09       Impact factor: 5.078

2.  Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS.

Authors:  Seth C Kalichman; Lisa Eaton; Moira O Kalichman; Tama Grebler; Cynthia Merely; Brandi Welles
Journal:  J Behav Med       Date:  2016-07-09

3.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

4.  Medication adherence in people dually treated for HIV infection and mental health conditions: test of the medications beliefs framework.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christopher Kegler; Chauncey Cherry; Moira O Kalichman
Journal:  J Behav Med       Date:  2015-04-03

Review 5.  Implementation challenges for long-acting antivirals as treatment.

Authors:  Diane Havlir; Monica Gandhi
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

6.  The differences between medical trust and mistrust and their respective influences on medication beliefs and ART adherence among African-Americans living with HIV.

Authors:  Jennifer A Pellowski; Devon M Price; Aerielle M Allen; Lisa A Eaton; Seth C Kalichman
Journal:  Psychol Health       Date:  2017-05-05

7.  Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures.

Authors:  J T Schousboe; B E Dowd; M L Davison; R L Kane
Journal:  Osteoporos Int       Date:  2009-12-05       Impact factor: 4.507

8.  What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders.

Authors:  Jada G Hamilton; Sarah E Lillie; Dana L Alden; Laura Scherer; Megan Oser; Christine Rini; Miho Tanaka; John Baleix; Mikki Brewster; Simon Craddock Lee; Mary K Goldstein; Robert M Jacobson; Ronald E Myers; Brian J Zikmund-Fisher; Erika A Waters
Journal:  J Behav Med       Date:  2016-08-26

9.  Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART.

Authors:  Matthew P Fox; Arthur Mazimba; Phil Seidenberg; Denise Crooks; Bornwell Sikateyo; Sydney Rosen
Journal:  J Int AIDS Soc       Date:  2010-03-06       Impact factor: 5.396

10.  Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study.

Authors:  Mison Dahab; Salome Charalambous; Alan S Karstaedt; Katherine L Fielding; Robin Hamilton; Lettie La Grange; Gavin J Churchyard; Alison D Grant
Journal:  BMC Public Health       Date:  2010-07-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.